What is Vera Therapeutics's long-term debt?

Vera Therapeutics (VERA) reported long-term debt of $75.03M in Q1 2026.

How has Vera Therapeutics's long-term debt changed year-over-year?

Vera Therapeutics's long-term debt increased by 47.4% year-over-year, from $50.91M to $75.03M.

What does long-term debt mean?

Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.

Vera Therapeutics VERA Long-Term Debt

Long-Term Debt at other companies

Viridian Therapeutics, Inc.VRDN

$36.09M+74.5%

ImmunityBio, Inc.IBRX

$404.3M+36.5%

BiohavenBHVN

$241.91M—

Johnson & JohnsonJNJ

$37.53B-2.2%

Merck & Co.MRK

$49.1B+41.1%

TG TherapeuticsTGTX

$745.14M+204%

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebt.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's long-term debt?: Vera Therapeutics (VERA) reported long-term debt of $75.03M in Q1 2026.
How has Vera Therapeutics's long-term debt changed year-over-year?: Vera Therapeutics's long-term debt increased by 47.4% year-over-year, from $50.91M to $75.03M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.